Asuragen In Brief This Week: Bio-Techne, Dante Labs, Metagenomi, Applied DNA Sciences, Caris Life Sciences News items for the week of April 5, 2021. Bio-Techne Seeks to Build Out 'Substantial Diagnostics Presence' With Asuragen Buy Premium Bio-Techne expects the acquisition will provide it with a basis to build out its IVD presence, given Asuragen's diagnostic tests and regulatory expertise. Bio-Techne to Acquire Molecular Diagnostics Firm Asuragen for up to $320M Bio-Techne said Asuragen's headquarters in Austin, Texas includes a scalable 50,000-square-foot manufacturing facility and CLIA-certified laboratory. Pacific Biosciences, Asuragen Collaborate on Clinical Assays Asuragen will develop assays for PacBio's long-read next-generation sequencing systems, with an initial focus on developing a carrier screening assay. Asuragen Receives CE Mark for Spinal Muscular Atrophy Assay The test can help diagnose spinal muscular atrophy and identify carriers without symptoms who may be at risk of passing the disease to their children. Feb 23, 2020 Asuragen Fragile X Diagnostic Test Gets FDA Authorization Nov 25, 2019 Asuragen, Wave Life Sciences to Develop Companion Diagnostics for Huntington's Disease Therapies Dec 4, 2018 Asuragen Myotonic Dystrophy 1 Dx Kit Receives CE Mark Nov 13, 2018 Health Canada Approves Two BCR-ABL Tests Oct 22, 2018 Asuragen, RTI Collaborate on Fragile X Syndrome Testing Oct 19, 2018 People in the News: Mary Padbury, Katherine Bach Kalin, Daniel Kolk, More Sep 7, 2018 Asuragen ALS, Dementia Assay Gets Favorable Evaluation From UPenn Team Premium Sep 7, 2018 New Products Posted to GenomeWeb: Genoptix, Asuragen Sep 5, 2018 Asuragen Gets CE Mark for QuantideX NGS Oncology Panel Jul 27, 2018 New Products Posted to GenomeWeb: SeraCare, Asuragen, Biofortuna, More Jun 1, 2018 New Products Posted to GenomeWeb: PerkinElmer, Phase Genomics, Pacific Biosciences, Asuragen, More Jan 17, 2018 Asuragen Gets CE Mark for QuantideX BCR-ABL Kits on Roche Platform Feb 21, 2017 Asuragen to Develop IVD Kits on Thermo Fisher Scientific's CE Platform Dec 12, 2016 Asuragen Research Correlates FMR1 Methylation, Symptoms in Fragile X-Associated Motor Disorder Premium Jul 25, 2016 Asuragen BCR-ABL Kit Granted FDA Premarket Clearance May 19, 2016 Surgical Decisions for Thyroid Nodules Often Not Affected By Molecular Testing Sep 9, 2015 Illumina, Asuragen to Collaborate on Companion Diagnostics Development Jun 11, 2015 Asuragen BCR-ABL Assay Receives CE Mark Dec 10, 2014 Additional Members Join UK Cancer Consortium Dec 5, 2014 Study Shows FFPE Pre-PCR Processing Problems Plague Pathology Labs Premium Load More Breaking News Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project BGI Americas Collaborating With Champions Oncology on Proteomic Cancer Research Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System The Scan Missed Early Cases A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports. Limited Journal Editor Diversity A survey finds low diversity among scientific and medical journal editors, according to The Scientist. How Much of a Threat? Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned. PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.